Cancer costs and outcomes for common cancer sites in the Finnish population between 2009–2014

References

• Luengo-Fernandez R, Leal J, Gray A, et al. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol. 2013;14:1165–1174.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.
   PubMed Web of Science ®Google Scholar
• Møller H, Fairley L, Coupland V, et al. The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer. 2007;96:1484–1488.
   PubMed Web of Science ®Google Scholar
• Jönsson B, Wilking N. The burden and cost of cancer. Ann Oncol. 2007;18:8–22.
   Web of Science ®Google Scholar
• Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12:933–980.
   PubMed Web of Science ®Google Scholar
• Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103:117–128.
   PubMed Web of Science ®Google Scholar
• Institutet för Hälso-och Sjukvårdsekonomi (Institute of Health and Health Economics; IHE).Kostnader för cancer I Sverige idag och år 2040 [Institute of Health and Health Economics (IHE). Cancer costs in Sweden today and year 2040]. IHE Rapport 2016:1. Available from: http://res.cloudinary.com/cancerfonden/image/upload/v1459776752/documents/ihe-rapport-2016.pdf
   Google Scholar
• Mäklin S, Rissanen P. Syöpien aiheuttamat kustannukset: Hoito- ja tuottavuuskustannusten kehitys vuosina 1996–2004 ja ennuste niiden muutoksista vuoteen 2015. [Costs caused by cancers: Development of cost of care and productivity in 1996–2004 and forecast of their changes by 2015] Suomen Syöpäyhdistyksen Julkaisuja [Publications of the Finnish Cancer Society]. 2006. [in Finnish].
   Google Scholar
• Tangka FK, Trogdon JG, Richardson LC, et al. Cancer treatment cost in the United States: has the burden shifted over time? Cancer. 2010;116:3477–3484.
   PubMed Web of Science ®Google Scholar
• Bradley CJ, Yabroff KR, Dahman B, et al. Productivity costs of cancer mortality in the United States: 2000–2020. J Natl Cancer Inst. 2008;100:1763–1770.
   PubMed Web of Science ®Google Scholar
• Warren JL, Yabroff KR, Meekins A, et al. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100:888–897.
   PubMed Web of Science ®Google Scholar
• Torkki P, Leskelä R, Linna M, et al. Cancer costs and outcomes in the Finnish population 2004–2014. Acta Oncologica. 2018; 57:297–303.
   PubMed Web of Science ®Google Scholar
• Finnish Cancer Registry. 2016 [Internet]. Cancers in 2030. Available from: https://www.cancersociety.fi/publications/reports/cancer-in-finland-2016/cancers-in-2030/
   Google Scholar
• Yabroff KR, Lamont E, Mariotto A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100:630–641.
   PubMed Web of Science ®Google Scholar
• Mittmann N, Porter JM, Rangrei J, et al. Health system costs for stage-specific breast cancer: a population-based approach. Curr Oncol. 2017;21:281–293.
   Web of Science ®Google Scholar
• Mogen TA, Bjørnelv GMW, Aas E. Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway. Eur J Health Econ. 2016;17:745–754.
   PubMed Web of Science ®Google Scholar
• Blumen H, Fitch K, Polkus V. Comparison of treatment costs for breast cancer, by tumor stage and type of service. Am Health Drug Benefits. 2016;9:23–32.
   PubMed Web of Science ®Google Scholar
• Roehrborn CG, Black LK. The economic burden of prostate cancer. BJU Int. 2011;108:806–813.
   PubMed Web of Science ®Google Scholar
• Laudicella M, Walsh B, Burns E, et al. Cost of care for cancer patients in England: evidence from population-based patient-level data. Br J Cancer. 2016; 114:1286–1292.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. International Classification of Diseases, 10th revision (ICD-10). Malta; 2011.
   Google Scholar
• Statistics Finland [Internet]. 2017. Available from: http://www.stat.fi/index_en.html
   Google Scholar
• Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health. 2001;22:91–113.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Welfare. Health expenditure and financing 2014 [Internet]. Available from: http://www.julkari.fi/handle/10024/130783
   Google Scholar
• Venesmaa J. Organizing a maternity care service network [Licenciate thesis]. Espoo: Aalto University; 2011.
   Google Scholar
• Finnish Tax Administration [Internet]. Available from: https://www.vero.fi/en-US
   Google Scholar
• Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015; 385:977–1010.
   PubMed Web of Science ®Google Scholar
• De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15:23–34.
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 2010;11:165–173.
   PubMed Web of Science ®Google Scholar
• Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377:127–138.
   PubMed Web of Science ®Google Scholar
• Porter ME. What is value in health care? N Engl J Med. 2010; 363:2477–2481.
   PubMed Web of Science ®Google Scholar